Document is current
Any future updates will be listed below
-
Authors
Wu, Congzi
Xu, HuiHui
Wu, Zhen
Huang, Haipeng
Ge, Qinwen
Xu, Jianbo
Chen, Jiali
Wang, Pinger
Yuan, Wenhua
Jin, Hongting
Tong, Peijian
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (82274280 and 82274547)
National Natural Science Foundation of Zhejiang Province (LD22C060002)
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 24 April 2025
First Online: 9 May 2025
Declarations
:
: The procedures of this study entitled ‘Subchondral injection of human umbilical cord mesenchymal stem cells ameliorates knee osteoarthritis by inhibiting osteoblast apoptosis and TGF-beta activity’ were approved by the Experimental Animal Ethics Committee of Zhejiang Chinese Medical University on October 10, 2022 (No. 20221010-13) and conducted complied with the ARRIVE guidelines and NIH Guide for the Care and Use of Laboratory Animals. S-Evans Biosciences, the original source, confirmed that the collection of human cells received initial ethical approval and that signed informed consent forms were obtained from all donors. The original publication detailing this information can be accessed at: .
: Not applicable.
: The authors declare no conflict of interest.
